ATF3 and metabolic dysfunction-associated steatotic liver disease: This result agrees with those of previous studies suggesting that ATF3 is upregulated in patients with NAFLD and murine models and inhibits the expression of PCK1 in alcoholic fatty liver disease17,39,40.